Herpes simplex virus latency and the immune response

Current Opinion in Microbiology

Volumn 1, Issue 4, 1998, Pages 430-435

  Daheshia, Massoud ^a   Feldman, Lawrence T ^b   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERPES; SIMPLEXVIRUS;

HERPES SIMPLEX; HUMAN; IMMUNOLOGY; NEUROLOGIC DISEASE; REVIEW; VIROLOGY; VIRUS ACTIVATION; VIRUS LATENCY;

HERPES SIMPLEX; HUMANS; NERVOUS SYSTEM DISEASES; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 0032129793     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(98)80061-1     Document Type: Article

References (50)

1. Whitley RJ: Herpes simplex viruses. In Field's Virology, edn 3, Edited by Field BN, Knipe DM, Howley PM. Philadelphia: Lippincott Raven Pub; 1996:2297-2342.
2. Wald A, Zeh J, Selk S, Ashley RL, Corey L: Virologic characteristics of subclinical and symptomatic genital herpes infection. New Engl J Med 1995, 333:770-775.
3. Cook SK, Hill JM, Lynas C, Matiland NJ: Latency associated transcripts in corneas and ganglia of HSV-1 infected rabbits. Br J Ophthalmol 1991, 75:644-648.
4. O'Hare P: The virion transactivator of herpes simplex virus. Semin Virol 1993, 4:145-155.
5. Kristie TM, Lebowitz JH, Sharp PA: The octamer-binding proteins form multi-protein DNA complexes with the HSV alpha TIF regulatory protein. EMBO J 1989, 8:4229-4238.
6. LaMarco K, McKnight S: Purification of a set of cellular polypeptides that bind to the purine-rich cis-regulatory element of herpes simplex virus immediate early genes. Genes Dev 1989, 3:1372-1383.
7. Roizman B, Sears AE: Herpes simplex viruses and their replication. In Field's Virology edn 3. Edited by Fields BN, Knife DM, Howley PM. Philadelphia: Lippencott Raven Pub; 1996:2231-2295.
8. Perng GC, Ghiasi H, Slanina SM, Nesburn AB, Wechsler SL: High dose ocular infection with a herpes simplex virus type-1 ICP 34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivation. J Virol 1996, 70:2883-2893.
9. Stanberry LR: Animal models and HSV latency. Semin Virol 1994, 5:213-219.
10. Steiner I, Spivack JG, Deshmane SL, Ace Cl, Preston CM, Fraser NW: A simplex virus type-1 mutant containing a non-transducing VMW65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia. J Virol 1990, 64:1630-1638.
11. 89Sr mediate genetic resistance to herpes simplex virus-1 infection. Infect Immun 1980, 28:1028-1032.
12. Zawatsky R, Gresser I, DeMaeyer E, Krichner H: The role of interferon in the resistance of C57 BL/6 mice to various doses of herpes simplex virus type-1. J Infect Dis 1982, 146:405-410.
13. Halford WP, Veress LA, Gebhardt BM, Carr DJJ: Innate and acquired immunity to herpes simplex virus type-1. Virology 1997, 236:328-337.
14. Sodeik B, Ebersold MW, Helenius A: Microtubule-mediated transport of incoming herpes simplex virus-1 capsids to the nucleus. J Cell Biol 1997, 135:1007-1021.
15. Nishiyama Y, Kurachi R, Daikoku T, Umene K: The US9, 10, 11 and 12 genes of herpes simplex virus type-1 are of no importance for its neurovirulence and latency in mice. Virology 1993, 194:419-423.
16. Margolis TP, Sedarati F, Dobson AT, Feldman LT, Stevens JG: Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology 1992, 189:150-160.
17. Cantin EM, Hinton DR, Chen J, Openshaw H: Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type-1. J Virol 1995, 69:4898-4905.
18. Halford WP, Gebhardt BM, Carr DJJ: Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type-1. J Immunol 1996, 157:3542-3549.
19. Lui T, Tang Q, Hendricks RL: Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus corneal infection. J Virol 1996, 70:264-271.
20. Spear PG, Roizman B: Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpes virion. J Virol 1972, 9:143-159.
21. Sears AE, Hukhanen V, Labow MA, Levine AJ, Roizman B: Expression of the herpes simplex 1 alpha-transducing factor (VP16) does not induce reactivation of latent virus or prevent the establishment of latency in mice. J Virol 1991, 65:2929-2935.
22. He X, Treacy MN, Simmons DM, Ingraham HA, Swanson LS, Rosenfeld MG: Expression of a larger family of pou-domain regulatory genes in mammalian brain development. Nature 1989, 340:35-42.
23. Tal-Singer R, Lasner TM, Podrzucki W, Skokotas A, Leary JJ, Berger SL, Fraser NW: Gene expression during reactivation of herpes simplex virus type-1 from latency in the peripheral nervous system is different from that during lytic infection of tissue cultures. J Virol 1997, 71:5268-5276. Using a mouse trigeminal explant model and reverse transcriptase PCR, the pattern of viral and cellular gene expression during reactivation was investigated. The induction of neuronal transcription factors such as Oct-1, c-Jun, c-Fos, and c-Myc was shown and early viral transcripts were detected before immediate-early transcripts, indicating that the neuronal lytic cycle may proceed in a unique way.
24. Lillycrop KA, Dent CL, Wheatley SC, Beech MN, Minkina NN, Wood JN, Latchman DS: The octamer-binding protein Oct-2 represses HSV immediate- early genes in cell lines derived from latently infected sensory neurons. Neuron 1991, 7:381-390.
25. Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman LT: RNA complementary to a herpes virus gene mrna is prominent in latently infected neurons. Science 1987, 235:1056-1059.
26. Farrell MJ, Dobson AT, Feldman LT: Herpes simplex virus latency-associated transcripts is a stable intron. Proc Natl Acad Sci USA 1991, 88:790-794.
27. Thompson R, Sawtell NM: The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J Virol 1997, 71:5432-5440. Using a novel technique to analyze viral nucleic acid events in single cells from the trigeminal ganglion, the authors conclude that the LAT gene is not involved during reactivation from latency.
28. Garber DA, Schaeffer PA, Knipe DM: A LAT associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1. J Virol 1997, 71:5885-5893. This report, using LAT-minus mutants, provides evidence that the virus play an active role in downregulating productive infection during acute infection of sensory neurons. These observations were suggested as a mechanism which permits the virus to evade the host immune response and to reduce viral cytopathic effects, allowing neuronal survival and establishment of latency.
29. Bloom DC, Hill JM, Devi-Rao, G, Wagner EK, Feldman CT, Stevenes JG: A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J Virol 1996, 70:2449-2459.
30. Rock DL, Fraser NW: Detection of HSV-1 genome in the central nervous system of latently infected mice. Nature 1983, 302:523-525.
31. Deshmane SL, Fraser NW: During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J Virol 1989, 63:943-947.
32. Chen X, Schmidt MC, Glorioso JC: Two herpes simplex virus type 1 latency-active promoters differ in their contributions to the latency-associated transcript expression during lytic and latent infection. J Virol 1995, 69:7899-7908.
33. Block TM, Hill JM: The latency associated transcripts (LATs) of herpes simplex virus: still no end in sight J Neurovirol 1997, 3:313-321.
34. Wassengger M, Heimes S, Riedel W, Sanger HL: RNA directed de novo methylation of genomic sequences in plants. Cell 1994, 76:567-576.
35. Cavalle J, Nicoloso M, Bachellerie J: Targeted ribose methylation of RNA in vivo directed by tailored antisense RNA guides. Nature 1996, 383:732-735.
36. Chen SH, Kramer MF, Schaffer PA, Coen DM: A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus. J Virol 1997, 71:5878-5884. The effect of a deletion mutation in the latency-associated transcript (LAT) locus on viral gene expression was analyzed in latently infected mouse trigeminal ganglia. The reduced expression of LAT resulted in reduced expression of ICP4 and thymidine kinase, which was taken to mean that LAT represses the accumulation of transcripts from two productive-cycle genes in latently infected mouse ganglia.
37. Ho DY, Mocarski ES: Herpes simplex virus latency RNA (LAT) is not required for latency infection in the mouse. Proc Natl Acad Sci USA 1989, 86:7596-7600.
38. Perng GC, Chiasi H, Slanina SM, Nesburn AB, Wechsler SL: The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript. J Virol 1996, 70:976-984.
39. + cytotoxic T lymphocyte precursors specific for herpes simplex viruses in persons with genital herpes. J Virol 1996, 70:8165-8168.
40. Leib DA, Bogard CL, Kosz-Vnenchak M, Hicks KA, Coen DM, Knipe DM, Schaffer PA: A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J Virol 1989, 63:2893-2900.
41. Krause PR, Stanberry LR, Bourne N, Connelly JF, Kurawadwala A, Patel A, Straus SE: Expression of the herpes simplex virus type 2 latency-associated transcript enhanced spontaneous reactivation of genital herpes in latently infected guinea pigs. J Exp Med 1995, 81:297-306.
42. Kosz-Vnenchak M, Jacobson J, Coen DM, Knipe DM: Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J Virol 1993, 67:5383-5393.
43. Wang K, Pesnicak L, Straus SE: Mutations in the 5′ end of the herpes simplex virus type 2 latency-associated transcript (LAT) promoter affect LAT expression in vivo but not the rate of spontaneous reactivation of genital herpes. J Virol 1997, 71:7903-7910.
44. Russel J, Stow ND, Stow EC, Preston CM: Herpes simplex virus genes involved in latency in vitro. J Gen Virol 1987, 68:3009-3018.
45. Leib DA, Coen DM, Bogard CL, Hicks KA, Yager DR, Knipe DM, Tyler KL, Schaffer PA: Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol 1989, 63:759-768.
46. Harris RA, Everett RD, Zhu X, Silverstein S, Preston CM: Herpes simplex virus type 1 immediate-early protein VmW 110 reactivates latent herpes simplex virus type 1 in an in vitro latency system. J Virol 1989, 63:3513-3515.
47. Zhu Z, Chen J, Young CSH, Silverstein S: Reactivation of latency herpes simplex virus by adenovirus recombinants encoding mutant IE-0 gene products. J Virol 1990, 64:4489-4498.
48. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J: Frequent genital herpes simplex virus 2 shedding in the immunocompetent woman. Effect of acyclovir treatment. J Clin Invest 1997, 99:1092-1097.
49. Schmid DS, Rouse BT: The role of T cell immunity in control of herpes simplex virus. Curr Top Microbiol Immunol 1992, 179:57-74.
50. Altman JD, Reay PA, Davis MM: Formation of functional peptide complexes of class II major histocompatibility complex proteins from subunits produced in Escherichia coli. Proc Natl Acad Sci USA 1993, 90:10330-10334.